No, I prefer this, I must say, for protecting the health and safety of Canadians.
Accordingly, we've taken its development very seriously.
The legislation has already benefited from a series of meetings with over 400 stakeholders since it was tabled, including some of the witnesses you've already heard from. Through these discussions several common themes have emerged. These themes will provide the basis for continued stakeholder dialogue on elements of the proposed regulations moving forward. Our objective in working with stakeholders is to make sure that the program and the regulatory framework strike a balance between the needs of biosafety and biosecurity and the interests of ongoing science and research.
We have heard this committee.
We at the Public Health Agency of Canada will do whatever is necessary to provide this committee with the assurances needed.
We will follow through with our stated intentions regarding the program and regulatory framework, and I think you've seen the regulatory framework. In light of recent dialogue around this bill we will redouble our efforts to engage the stakeholders and to listen and respond to their concerns in keeping with the commitments we have made before this committee and across the country. We have made available this program and regulatory framework document earlier this week. I think you'll find it a good discussion point to start from with respect to a number of concerns that people have raised.
Let me thank you again for your time and thought. We are here to try to address all the questions you might raise.
Madam.